The reiteration of a Buy rating and maintenance of an $85 price target by a reputable analyst like Joseph Stringer could positively influence investor sentiment towards Apellis Pharmaceuticals. This endorsement may lead to increased investor confidence and potentially drive the stock price up in the short term.